ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Transcatheter Mitral Intervention

November 4, 2022
In June 2022, a panel of cardiothoracic surgery experts gathered at University Hospital Ospedali Riuniti in Ancona, Italy to discuss minimally invasive and transcatheter surgery. This live virtual course was directed by Professor Marco Di Eusanio. Each session broadcast a surgery from an OR and featured a discussion from surgeons. 
July 15, 2022
In this article, the authors provide a step-by-step illustrated guide to performing transcatheter edge-to-edge mitral valve repair (MitraClip). This is a key article that will be of benefit to all learning to perform MitraClip. 
June 4, 2021
On May 25, 2021, Dr. David Heimansohn successfully performed the first surgical implantation of biopolymer Tria™ heart valve in a patient with mitral valve disease at Ascension St. Vincent Hospital, Indianapolis, IN. 
April 15, 2021
In the special April issue of JACC Imaging focusing on secondary mitral regurgitation (SMR), a number of articles on outcomes after transcatheter edge-to-edge repair (TEER) are reported. Specifically, the concept of proportionate vs disproportionate SMR was explored.
February 21, 2021
In this article, Kilcoyne et al discuss the current status of training cardiothoracic surgery trainees in structural heart disease and propose a new core curriculum for training surgeons in structural heart disease. 
October 8, 2019
An interesting pilot experiment on attempting to quantify the optimum disposition of neochordae in transapical intervention for severe mitral regurgitation.
October 6, 2019
The authors address appropriate use of the transcatheter clip to treat degenerative mitral regurgitation in elderly low to moderate risk patients.
August 25, 2019
In an era of increased use of MitraClip, surgical mitral valve repair still offers a durable solution.  Tirone David and colleages report 1,234 consecutive patients who had mitral valve repair with 20 year follow-up.  
July 16, 2019
Abbott announced that its fourth-generation MitraClip device, MitraClip G4, was approved by the US Food and Drug Administration on July 15, 2019, to treat mitral regurgitation (MR) in a wider population of patients.  The MitraClip G4 include new clip sizes and an enhanced leaflet grasping feature

Pages